PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16180173-10 1999 In a clinical trial, ABX-CBL was administered to ten patients with acute steroid-resistant GvHD. Steroids 73-80 Cbl proto-oncogene Homo sapiens 25-28 11567989-0 2001 Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL. Steroids 13-20 Cbl proto-oncogene Homo sapiens 104-107 12939720-9 2003 Daclizumab, infliximab, visilizumab, and ABX-CBL have shown promising activity in steroid-resistant acute GvHD in early clinical testing. Steroids 82-89 Cbl proto-oncogene Homo sapiens 45-48